Company / Operating Income per Share
NewAmsterdam Pharma Co N.V. Operating Income per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$6.22
FY2025
5-year range
-$6.22 / -$0.19
FY2021-FY2025
Trend
-28.0%
vs FY2024
Sector context
#178 of 201
Health Care
What the data says
NewAmsterdam Pharma Co N.V.'s operating income per share of $-6.22 is lower than 89% of companies in the Health Care sector (FY2025). Operating Income per Share has fluctuated over the past 5 years, ranging from $-6.22 in FY2025 to $-0.19 in FY2022.
Based on SEC 10-K filings.
-6.22 in FY2025.
Declined from $-5.05 to $-6.22 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 201This company -$6.22 Sector average -$28.56
▼
+78.2% above sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 28.0% year-over-year.
- Ranks #178 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$6.22 | -28.0% |
| FY2024 | -$4.86 | +3.6% |
| FY2023 | -$5.05 | -2590.7% |
| FY2022 | -$0.19 | +94.1% |
| FY2021 | -$3.19 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026